Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clitoria ternatea extract, derived from the **Butterfly Pea** plant, is a bioactive botanical preparation rich in polyphenols, including anthocyanins (such as delphinidins), tannins, and clitorienolactones. The extract is widely investigated for its multi-target pharmacological properties, specifically its neuroprotective, antidiabetic, and antiobesity effects. In pre-clinical models, it has demonstrated the ability to mitigate hyperglycemia and weight loss, reduce oxidative stress, and inhibit the formation of **advanced glycation end products (AGEs)**, which are implicated in diabetic complications. Root-derived compounds like clitorienolactones A and B appear to modulate hippocampal neuroplasticity and improve cognitive function by sustaining intracellular calcium levels and interacting with **NMDA receptors**. Additionally, the extract's pH-sensitive anthocyanins make it a valuable natural colorant and an intelligent packaging indicator for monitoring food freshness in the food science industry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on clitoria ternatea extract.